compounded semaglutide being discontinued Discontinued? Current Status Did the FDA Ban Compounded

The review contextualised native GLP-1 as the reference molecule for the entire dual GIP/GLP-1 receptor agonist research field including tirzepatide (approved) and novel triple agonists targeting GLP-1R, GIPR, and GCGR simultaneously confirming native GLP-1s ongoing research importance as the pharmacological anchor of this rapidly expanding compound class

Receptor biology is not background to the GLP-1 story

Based on currently available clinical data, retatrutide has demonstrated some of the largest average weight loss outcomes among injectable weight loss medications

Choose a convenient day each week for your injection and maintain that routine

Stay up to date with FDA policies and adjust prescriptions accordingly

Those pursuing maximum possible results may require the full 12mg dose